[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Rackham Rishel [@RackhamRishel](/creator/twitter/RackhamRishel) on x 12.2K followers Created: 2025-07-18 13:11:21 UTC MEI Pharma’s move to integrate Litecoin into its treasury signals growing institutional confidence in crypto assets. Partneing with GSR and Titan Partners underlines a strategic diversification beyond traditional reserves. This could set a precedent for other firms seeking crypto exposure on Nasdaq. The lines between biotech and blockchain are clearly blurring. XXX engagements  **Related Topics** [blockchain](/topic/blockchain) [nasdaq](/topic/nasdaq) [asset allocation](/topic/asset-allocation) [titan](/topic/titan) [signals](/topic/signals) [litecoin](/topic/litecoin) [coins layer 1](/topic/coins-layer-1) [coins pow](/topic/coins-pow) [Post Link](https://x.com/RackhamRishel/status/1946196091340509238)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Rackham Rishel @RackhamRishel on x 12.2K followers
Created: 2025-07-18 13:11:21 UTC
MEI Pharma’s move to integrate Litecoin into its treasury signals growing institutional confidence in crypto assets. Partneing with GSR and Titan Partners underlines a strategic diversification beyond traditional reserves. This could set a precedent for other firms seeking crypto exposure on Nasdaq. The lines between biotech and blockchain are clearly blurring.
XXX engagements
Related Topics blockchain nasdaq asset allocation titan signals litecoin coins layer 1 coins pow
/post/tweet::1946196091340509238